Summary: Whitehawk Minerals Corp. is expected to price its IPO at the midpoint of the $25 to $27 range next week, following a one-week delay to respond to U.S. Securities and Exchange Commission comments. The planned deal - originally structured to sell roughly 6.9 million shares and raise up to $187 million - is set to be upsized in response to demand that reportedly exceeds available stock by several times.
Whitehawk postponed the pricing originally slated for this week in order to address comments from the SEC, and the firm has not yet fixed a new calendar date for the pricing event. The delay is procedural and timing remains undetermined, according to the report.
Investor interest in the offering has been concentrated among long-only funds and managers that specialize in the energy sector. That demand profile has prompted lead managers to increase the size of the offering to accommodate orders that exceed the available allocation by multiple times.
Prior to the decision to upsize, Whitehawk had indicated plans to offer roughly 6.9 million shares at a price band of $25 to $27 per share, a structure that would yield gross proceeds up to $187 million if sold at the top of the range. The company intends for its shares to begin trading on the New York Stock Exchange under the ticker symbol WHK.
Major underwriting banks on the transaction include Raymond James Financial Inc., Stifel Financial Corp., and JPMorgan Chase & Co., among others. These firms are coordinating the bookbuilding process, allocating shares between long-only institutional demand and energy-dedicated investors.
While pricing is expected to come at the midpoint of the marketed range, market participants should note that the precise timing for the transaction's pricing has not been determined and remains dependent on completion of the process to address regulator comments.
Context for market participants: The combination of strong demand from energy-focused investors and long-only funds has led to an increase in the offering's size. The company and its underwriters are balancing those orders with the regulatory review process, which introduced the delay.